Drug application
EXCEDRIN (MIGRAINE RELIEF) (ACETAMINOPHEN, ASPIRIN, CAFFEINE)
Drugs@FDA NDA 020802 · HALEON US HOLDINGS
Key facts
| Drug name | EXCEDRIN (MIGRAINE RELIEF) |
|---|---|
| Active ingredients | ACETAMINOPHEN, ASPIRIN, CAFFEINE |
| Application type | NDA |
| Application number | 020802 |
| Company | HALEON US HOLDINGS |
| Dosage forms | TABLET, ORAL |
| Strength | 250MG;250MG;65MG |
| Marketing status | Over-the-counter |
| Reference listed drug | Yes |
| Latest submission class | Type 3 - New Dosage Form |
| Latest submission status date | Jan 14, 1998 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 10–99 Label versions
- 1–9 Products
- None Therapeutic equivalents
- No FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: